Glenmark Life Sciences Limited had a revenue of 5.88B in the quarter ending Sep 30, 2024, with -0.11%. This bring the company's revenue in the last twelve months to 11.90B, Increased -48.09%. In the fiscal year ending Mar 31, 2024, Glenmark Life Sciences Limited had annual revenue of 23.72B with 11.71% growth.